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Background
Nitroxyl (HNO) is a redox congener of NO•. We now
directly compare the antihypertrophic efficacy of HNO
and NO• donors in cardiomyocytes in vitro, and compare
their contributing mechanisms of actions in this setting. In
addition, the ability of the HNO donor isopropylamine-
NONOate to acutely limit hypertrophic responses in the
intact, beating rat heart was also determined.
Results
IPA-NO elicited concentration-dependent inhibition of
endothelin-1 (ET1)-induced increases in neonatal rat car-
diomyocyte size, with similar suppression of hypertrophic
genes. Antihypertrophic IPA-NO actions were significantly
attenuated by L-cysteine (HNO scavenger), Rp-8-pCTP-
cGMPS (cGMP-dependent protein kinase inhibitor), and
ODQ (to target soluble guanylyl cyclase, sGC), but were
unaffected by carboxy-PTIO (NO• scavenger) or CGRP8-
37 (calcitonin gene-related peptide antagonist). Further-
more, IPA-NO significantly increased cardiomyocyte
cGMP 3.5-fold (an L-cysteine-sensitive effect), and stimu-
lated sGC activity 3-fold, without detectable NO• release.
IPA-NO also suppressed ET1-induced cardiomyocyte
superoxide generation. The pure NO• donor, DEA-NO,
reproduced these IPA-NO actions, but were sensitive to
carboxy-PTIO rather than L-cysteine. Although IPA-NO
stimulation of purified sGC was preserved under pyrogal-
lol oxidant stress (in direct contrast to DEA-NO),
cardiomyocyte sGC activity after either donor were attenu-
ated by this stress. Excitingly IPA-NO also exhibited acute
antihypertrophic actions in response to acute pressure-
overload in the intact heart, at doses that did not affect
coronary perfusion pressure or LV function.
Conclusion
Our results demonstrate that the antihypertrophic actions
of HNO are broad, and not donor-specific, and are likely
independent of its vasodilator and other hemodynamic
actions. Given that HNO is impervious to reactivity with
superoxide, HNO donors may offer therapeutic advantages
over NO• donors. These studies further strengthen the
therapeutic promise of HNO donors and other non-nitro-
vasodilator means of cGMP-elevation as a novel strategy
for cardiac pathologies, as stand-alone and/or add-on ther-
apy to standard care.
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